Episode 440: An MS Specialist's Response to the FDA with Dr. William Conte
RealTalk MS2 Helmi

Episode 440: An MS Specialist's Response to the FDA with Dr. William Conte

This past December, the FDA issued a Complete Response Letter to drug manufacturer Sanofi in response to Sanofi's application seeking approval for Tolebrutinib, the first in a new category of investigational disease-modifying therapies to undergo FDA review. A Complete Response Letter is an official letter from the FDA to a drug manufacturer stating that the agency can't approve a new medicine in its current form. It's not an outright "no" that kills a project; it's more like a "not yet." However, this Complete Response Letter raised some issues which, at first glance, don't appear to be easily fixable.

Sanofi has pointed out that the issues raised in the Complete Response Letter were markedly different from the guidance they received from the FDA over the course of this approval process. Sanofi has also indicated that it would work with the FDA to find a path forward for Tolebrutinib.

Dr. William Conte, an MS Specialist and a principal investigator in the Phase 3 clinical trial for Tolebrutinib, has published an article responding to the FDA's Complete Response Letter. This week, Dr. Conte joins me to discuss the FDA's action and his response to that action.

We have a lot to talk about! Are you ready for RealTalk MS??!

This Week: We're at the 2026 ACTRIMS Forum :22

Check out the official ACTRIMS Forum Insider podcast! :42

The FDA's Complete Response Letter about Tolebrutinib 1:09

Dr. William Conte responds to the FDA's Complete Response Letter 4:09

Share this episode 38:10

Next week's episode 38:30

SHARE THIS EPISODE OF REALTALK MS

Just copy this link & paste it into your text or email: https://realtalkms.com/440

ADD YOUR VOICE TO THE CONVERSATION

I've always thought about the RealTalk MS podcast as a conversation. And this is your opportunity to join the conversation by sharing your feedback, questions, and suggestions for topics that we can discuss in future podcast episodes. Please shoot me an email or call the RealTalk MS Listener Hotline and share your thoughts!

Email: jon@realtalkms.com
Phone: (310) 526-2283

And don't forget to join us in the RealTalk MS Facebook group!

LINKS

If your podcast app doesn't allow you to click on these links, you'll find them in the show notes in the RealTalk MS app or at www.RealTalkMS.com

Support Jon at WALK MS
https://realtalkms.com/walkms

Find out about ABLEnow Accounts
https://ablenow.com

JOIN: The RealTalk MS Facebook Group
https://facebook.com/groups/realtalkms

REVIEW: Give RealTalk MS a rating and review
http://www.realtalkms.com/review

Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.

RealTalk MS Episode 440
Guests: Dr. William Conte

Privacy Policy

Jaksot(502)

Episode 38: The CMSC Annual Meeting with Dr. Rosalind Kalb, Marques Jones, Jill Blackburn & More

Episode 38: The CMSC Annual Meeting with Dr. Rosalind Kalb, Marques Jones, Jill Blackburn & More

At the Consortium of Multiple Sclerosis Centers Annual Meeting, I learned about the Pediatric MS Alliance from Jill Blackburn. I met Dr. Miriam Franco and learned about the app that she's developed an...

5 Kesä 201835min

Episode 37: MS & Sexual Function with Stuart Nixon, MBE

Episode 37: MS & Sexual Function with Stuart Nixon, MBE

I've invited a very special guest to talk about the subject that I've received -- by far -- the most requests to discuss on the podcast, and that's sexual function and MS. We're also talking about ...

29 Touko 201835min

Episode 36: Day Two From the International Progressive MS Alliance Scientific Congress on MS Rehabilitation & Symptom Management

Episode 36: Day Two From the International Progressive MS Alliance Scientific Congress on MS Rehabilitation & Symptom Management

The RealTalk MS podcast is coming to you from the Sheraton Centre Hotel in Toronto, Canada, where the International Progressive MS Alliance is holding its 3rd Scientific Congress. The theme of the eve...

25 Touko 201824min

Episode 35: Day One of the International Progressive MS Alliance Scientific Congress on MS Rehabilitation & Symptom Management

Episode 35: Day One of the International Progressive MS Alliance Scientific Congress on MS Rehabilitation & Symptom Management

Today -- and every day this week -- the RealTalk MS podcast is coming to you from the Sheraton Centre Hotel in Toronto, Canada, where the International Progressive MS Alliance is holding its 3rd Scien...

24 Touko 201830min

Episode 34: From the International Progressive MS Alliance Scientific Congress on MS Rehabilitation & Symptom Management

Episode 34: From the International Progressive MS Alliance Scientific Congress on MS Rehabilitation & Symptom Management

Today -- and every day this week -- the RealTalk MS podcast is coming to you from the Sheraton Centre Hotel in Toronto, Canada, where the International Progressive MS Alliance is holding its 3rd Scien...

23 Touko 201813min

Episode 33: From the International Progressive MS Alliance Scientific Congress on Rehabilitation & Symptom Management

Episode 33: From the International Progressive MS Alliance Scientific Congress on Rehabilitation & Symptom Management

Today -- and every day this week -- the RealTalk MS podcast is coming to you live from the Sheraton Centre Toronto Hotel in Toronto, Canada, where, tomorrow, the International Progressive MS Alliance ...

22 Touko 201816min

Episode 32: MS Rehabilitation & Symptom Management

Episode 32: MS Rehabilitation & Symptom Management

Living your best life while you're living with MS means learning how to manage and overcome the physical and psychological limitations that MS tries to impose. This week's guest, Dr. Kathleen Zackowsk...

15 Touko 201840min

Episode 31: David Mitchell & Patients For Affordable Drugs

Episode 31: David Mitchell & Patients For Affordable Drugs

In 2004, the average wholesale price of available MS disease-modifying therapies was $16,000. In 2013, the average price was $61,000; last year, the average price was more than $83,000. That's why my ...

8 Touko 201828min

Suosittua kategoriassa Terveys ja hyvinvointi

unicast
voi-hyvin-meditaatiot-2
psykopodiaa-podcast
tiedenaiset-podcast
rss-pitaisko-erota
vakeva-elama-viisaampi-mieli-vahvempi-keho
rss-narsisti
meditaatiot-suomeksi
terapiassa
junnut-pelissa
puhu-muru
aamukahvilla
rss-kuumilla-aalloilla
paritellen
rss-uplevel-by-sonja-hannus
rss-nautinto
rss-pt-paahtio
rss-mighty-finland-podcast
paaasia-podcast
katilon-kahvitunti